Showing results (311-320 of 344) with videos related to
Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)Sehhoon Park, Richard Baldry, Hyun Ae Jung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLCEun Ji Lee, Ji Ae Ko, Min-Je Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung CancerHyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|February 13, 2014
[Investigation on measles cases of new genotype D8 in Beijing, 2013]Juan Li, Li Lu, Rui Ma, et al.The Lancet. Oncology|December 24, 2011
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 studyJeeyun Lee, Se Hoon Park, Heung-Moon Chang, et al.Journal for Immunotherapy of Cancer|October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitorYeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 TrialYeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effectsIn Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.Journal for Immunotherapy of Cancer|October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purityTae Hee Hong, Hongui Cha, Joon Ho Shim, et al.Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.Pageof 35